Hashimoto Thyroiditis vs Graves Disease: How to Tell Them Apart
Both Hashimoto thyroiditis and Graves disease are autoimmune disorders of the thyroid marked by circulating antibodies and, often, a goiter. The core axis that separates them is function and mechanism: Hashimoto is T-cell–mediated destruction leading ultimately to hypothyroidism, while Graves is antibody-mediated stimulation of the TSH receptor causing hyperthyroidism. Master the TSH/Free T4 pattern, the antibody profile, and the presence of ophthalmopathy and you can distinguish them reliably.
How to tell them apart
| Feature | Hashimoto thyroiditis | Graves disease |
|---|---|---|
| Underlying mechanism | Autoimmune T-cell–mediated destruction of thyroid follicular cells; anti-TPO and anti-thyroglobulin antibodies are markers, not the primary driver | Thyroid-stimulating immunoglobulins (TSI) bind and activate the TSH receptor, stimulating the gland unchecked by feedback |
| Net thyroid function | Causes primary hypothyroidism (most common cause in iodine-sufficient areas), progressing from subclinical to overt | Causes primary hyperthyroidism (the most common cause) |
| TSH / Free T4 pattern | TSH elevated, Free T4 low (or normal in subclinical disease) | TSH suppressed, Free T4 and Free T3 elevated |
| Antibody profile | Anti-TPO antibodies positive in >90% of cases; anti-thyroglobulin antibodies may also be positive | TSI (thyroid-stimulating immunoglobulin) or TRAb (TSH receptor antibodies) positive |
| Ophthalmopathy | No eye findings | Ophthalmopathy — proptosis, lid retraction/lid lag, diplopia — is unique to Graves, driven by autoimmune inflammation of retroorbital tissues |
| Dermopathy | Absent | Pretibial myxedema (dermopathy) may occur, though rare |
| Clinical symptoms | Late disease produces hypothyroid features | Hyperthyroid features: heat intolerance, palpitations/tachycardia (may include atrial fibrillation), tremor, weight loss with increased appetite, anxiety, warm moist skin |
| Radioactive iodine uptake (RAIU) | Not a gland overproducing hormone; the destructive process shows low uptake | Diffusely increased uptake across the gland, reflecting active overproduction (may not be needed if the clinical picture is classic) |
The reasoning
Anchor first on the TSH/Free T4 pattern. TSH↑ with T4↓ signals primary hypothyroidism — check TPO antibodies, and their positivity clinches Hashimoto. TSH↓ with T4/T3↑ signals hyperthyroidism — then confirm the cause with RAIU or TSI/TRAb. In hyperthyroidism, diffusely increased RAIU plus positive TSI/TRAb establishes Graves. The single most decisive clinical arbiter is ophthalmopathy: prominent eyes with a hyperthyroid picture are specific to Graves. When the axis is unclear because Hashimoto is passing through an early hyperthyroid phase, use RAIU — a destructive process shows low uptake because it is not actively synthesizing hormone, unlike the high uptake of Graves.
Key tests
- TSH with Free T4: Hashimoto shows elevated TSH with low Free T4; Graves shows suppressed TSH with elevated Free T4/T3.
- Thyroid autoantibodies: anti-TPO (and often anti-thyroglobulin) positivity points to Hashimoto, while TSI/TRAb positivity confirms Graves.
- Radioactive iodine uptake (RAIU): diffusely high uptake indicates overproduction as in Graves, whereas destructive/thyroiditis processes show low uptake because the gland is not synthetically active.
What they share
- Both are autoimmune thyroid diseases with characteristic circulating antibodies as markers
- Both can produce a goiter (Hashimoto may enlarge or, in the atrophic form, shrink; Graves classically gives a diffuse goiter)
- Both can present with a hyperthyroid phase — Hashimoto transiently via 'hashitoxicosis' as stored hormone is released, and Graves as sustained hyperthyroidism
- Both are most relevant thyroid autoimmune conditions in iodine-sufficient populations and are diagnosed starting with TSH
Pitfalls
- Confusing early 'hashitoxicosis' with Graves: Hashimoto can cause transient hyperthyroidism from release of stored hormone before evolving to hypothyroidism — RAIU and antibody profile resolve the confusion.
- Assuming a goiter distinguishes them — both can produce goiters, and Hashimoto may instead be atrophic without enlargement.
- Forgetting that ophthalmopathy is specific to Graves and does not occur in Hashimoto (or in other causes of hyperthyroidism such as toxic nodules).
- Treating a destructive/thyroiditis hyperthyroid phase with antithyroid drugs — they won't work when the gland is not overproducing hormone.
- Over-relying on antibodies alone: anti-TPO can appear in autoimmune thyroid disease generally, so interpret antibodies alongside the TSH/T4 pattern and RAIU.
Practice this the way the exam tests it — on branching cases where your decisions shape the patient.